MeSH term
Frequency | Condition_Probility | 1-Phosphatidylinositol 3-Kinase/metabolism | 3 | 0.0 |
Cells, Cultured | 5 | 0.0 |
Comparative Study | 7 | 0.0 |
*Down-Regulation | 2 | 0.0 |
Humans | 28 | 0.0 |
Immunoblotting | 2 | 0.0 |
Insulin Resistance/*physiology | 2 | 2.0 |
Insulin-Like Growth Factor I/metabolism | 2 | 1.0 |
Phosphoproteins/*metabolism | 5 | 1.0 |
Proteins/metabolism | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 13 | 0.0 |
*Signal Transduction | 2 | 0.0 |
Animals | 22 | 0.0 |
Cell Line | 11 | 0.0 |
DNA Damage | 2 | 0.0 |
Dose-Response Relationship, Radiation | 4 | 1.0 |
Genetic Complementation Test | 2 | 0.0 |
Hamsters | 7 | 0.0 |
Mutation | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 24 | 0.0 |
Transfection | 6 | 0.0 |
1-Phosphatidylinositol 3-Kinase/*metabolism | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Mice | 13 | 0.0 |
Phosphoproteins/*physiology | 2 | 2.0 |
Rats | 5 | 0.0 |
Recombinant Proteins/metabolism | 2 | 0.0 |
src Homology Domains | 3 | 0.0 |
*Adaptor Proteins, Signal Transducing | 3 | 0.0 |
Homeostasis | 3 | 0.0 |
Insulin/metabolism | 4 | 2.0 |
Male | 10 | 0.0 |
Mice, Knockout | 4 | 0.0 |
Protein-Serine-Threonine Kinases/metabolism | 2 | 0.0 |
Proto-Oncogene Proteins/metabolism | 4 | 0.0 |
Receptor, Insulin/metabolism | 3 | 3.0 |
Signal Transduction/physiology | 3 | 0.0 |
Cricetulus | 5 | 1.0 |
Drug Resistance | 2 | 0.0 |
Phenotype | 3 | 0.0 |
Adult | 6 | 0.0 |
Aged | 4 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Case-Control Studies | 3 | 0.0 |
Female | 8 | 0.0 |
Genotype | 4 | 0.0 |
Insulin-Like Growth Factor I/*genetics | 2 | 8.0 |
Middle Aged | 5 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
Signal Transduction | 3 | 0.0 |
Amino Acid Sequence | 3 | 0.0 |
Molecular Sequence Data | 4 | 0.0 |
Phosphorylation | 6 | 0.0 |
Phosphotyrosine/metabolism | 3 | 0.0 |
Point Mutation | 2 | 0.0 |
Alleles | 2 | 0.0 |
Phosphoproteins/*genetics | 3 | 1.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Tumor Cells, Cultured | 4 | 0.0 |
Receptor, Insulin/physiology | 2 | 16.0 |
Gamma Rays | 2 | 0.0 |
Kinetics | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Mice, Inbred C57BL | 4 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Radiation Tolerance/*genetics | 2 | 3.0 |
Cell Line, Transformed | 2 | 0.0 |
DNA/drug effects/radiation effects | 2 | 15.0 |
Adolescent | 2 | 0.0 |
*Mutation | 3 | 0.0 |
*Protein-Serine-Threonine Kinases | 3 | 0.0 |
Signal Transduction/*physiology | 3 | 0.0 |
Phosphoproteins/genetics/*metabolism | 3 | 1.0 |
Gene Expression Regulation | 2 | 0.0 |
*Up-Regulation | 2 | 0.0 |
Ataxia Telangiectasia/*genetics | 2 | 3.0 |
*Intracellular Signaling Peptides and Proteins | 2 | 0.0 |
Glucose/metabolism | 4 | 1.0 |
Promoter Regions (Genetics) | 2 | 0.0 |
Insulin/*metabolism | 2 | 2.0 |